Refine by
Pathology Molecular Articles & Analysis
8 news found
The incidence of landscape fires has been rising globally, leading to increased exposure to landscape fire smoke (LFS) among millions of people. The inhalation of particulate matter (PM) from LFS is associated with adverse respiratory and cardiovascular outcomes. However, the mechanisms by which LFS impacts these functions remain inadequately understood. This blog focuses on a new ...
Molecular Health, an international biotech IT company based in Heidelberg, Germany, has received European Union certification for its MH Guide clinical decision support software (SaaS) under the new In Vitro Diagnostics Regulation (EU) 2017/746 (IVDR). The MH Guide software, which is used in molecular pathology laboratories, is the first of its ...
Molecular Health has launched the latest version of its analysis software MH Guide. This software, which is used by pathology laboratories and molecular tumor boards, now has improved search capabilities to identify patient- relevant clinical studies. ...
“We previously hypothesized that more aggressive molecular subtypes might be detectable based on their OA/US feature scores. ...
The instrument enables researchers to uncover unique molecular signatures that may be obscured in heterogeneous tumor samples. ...
One of the first commercially available high-sensitivity target-enrichment technologies for next-generation sequencing, HaloPlexHS incorporates more than 1 million unique molecular barcodes for accurate detection of alleles at low frequencies. The molecular barcodes are especially important for cancer researchers who work with heterogeneous samples in which ...
(NYSE: A) today introduced Agilent SureFISH probes, the next generation of fluorescent in situ hybridization (FISH) assays, delivering a comprehensive menu of the industry's highest resolution probes for a wide range of molecular analysis applications. Agilent SureFISH probes deliver dramatically better performance compared to existing FISH products. ...
The fund will target three broad areas for investment: Broad-based Diagnostics, including imaging, home health, patient monitoring, molecular diagnostics, pathology, novel imaging agents and other technologies for disease diagnosis. ...